-
Product Name
Recombinant IGLC6 protein (His tag)
- Documents
-
Description
Recombinant Immunoglobulin lambda constant 6 (Ig lambda-6 chain C region) fragment (amino acids 1-106) is a high-purity protein designed for studying the Ig-like domain's role in antibody structure and function. This fragment provides an essential tool for investigating humoral immunity mechanisms and antigen binding interactions.
Immunoglobulin lambda constant 6 serves as the constant region of immunoglobulin light chains, which are crucial glycoproteins produced by B lymphocytes. These immunoglobulins function as antigen receptors in the recognition phase of humoral immunity, triggering B cell expansion and differentiation into antibody-secreting plasma cells. The secreted immunoglobulins mediate the effector phase that eliminates bound antigens. Each immunoglobulin's antigen binding site is formed by variable domains from one heavy chain and its associated light chain, with the constant regions providing structural stability. The protein is naturally found both secreted and membrane-bound in human cells, playing a fundamental role in adaptive immune responses through its participation in antibody-mediated pathogen clearance.
-
Protein name
Immunoglobulin lambda constant 6
-
Uniprot ID
P0CF74
-
Gene Name
IGLC6
-
Source/Expression Host
E. coli
-
Expression Plasmid/cDNA
DNA encoding 1-106 aa (P0CF74) were fused with C-terminal 6His tag.
-
Sequence
MSKIKGQPKA APSVTLFPPS SEELQANKAT LVCLISDFYP GAVKVAWKAD GSPVNTGVET TTPSKQSNNK YAASSYLSLT PEQWKSHRSY SCQVTHEGST VEKTVAPAEC SLEHHHHHH
-
Protein Species
Human
-
Molecular weight
Predictes a molecular mass of 12.91 kDa. In SDS-PAGE under reducing conditions, it migrates as an approximately 16 kDa band.
-
Purity
>90%, by SDS-PAGE with Coomassie Brilliant Blue staining.
-
Activity
Not tested.
-
Validations
Recombinant IGLC6 protein (His tag) SDS-PAGE
M: Marker; Lane 1: IGLC6; Lane 2: BSA
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"